Brief: Paradigm Biopharmaceuticals Posts HY Net Loss Attributable A$27 Million
24/02/2022 24:31
Feb 24 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* HY NET LOSS ATTRIBUTABLE A$27 MILLION
Source text for Eikon: ID:nASX1KLYHt
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt